2008•Chinese Clinical OncologyRequires access

Clinical observation of the efficacy of transcatheter arterial chemoembolazition combined radio-frequency ablation in primary liver cancer

Si Qi, Pla Cancer

Abstract

Objective:To evaluate clinical efficacy of transcatheter arterial chemoembolazition sequentially combined radiofrequency ablation in the treatment of advanced primary lier cancer.Methods:Two hundred and thirty-seven cases with single advanced primary liver cancer(5-8cm)were divided into RFA group(n=69)and RFA combined with TACE group(n=168).The efficacy of the two groups through contrast-enhanced ultrasound were evaluated two weeks later.Results:According the imagement of contrast-enhanced ultrasound,the complete necrosis rate of tumor was 33%(23/69)in RFA,but it was 53%(91/169)in RFA combined with TACE group.Conclusion:Better therapeutic efficacy is expected by RFA combined with TACE in advanced primary liver cancer.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Radiofrequency ablation, Transcatheter arterial chemoembolization, Liver cancer, Ablation, Clinical efficacy, Primary cancer, Ultrasound